+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Astigmatism Epidemiology Forecast 2025-2034

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6092330
Astigmatism is a common vision ailment brought on by an irregularly shaped cornea or lens, which distorts or blurs vision at all distances. The prevalence of astigmatism, a common refractive error, is 40.4% in adults and 14.9% in children worldwide.

Astigmatism Epidemiology Forecast Report Coverage

The “Astigmatism Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of astigmatism. It projects the future incidence and prevalence rates of astigmatism across various populations. The study covers age, gender, and type as major determinants of the astigmatism-affected population. The report highlights patterns in the prevalence of astigmatism over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of astigmatism in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Astigmatism Disease Overview

Astigmatism is a common refractive error, brought on by an uneven corneal or lens curvature, which makes it difficult for light to focus correctly on the retina. This results in symptoms like headaches, eye strain, and trouble seeing at night, as well as blurred or distorted vision at all distances. It may be present from birth or develop over time, and it can coexist with nearsightedness (myopia) or farsightedness (hyperopia). Tests such as corneal curvature measurements and visual acuity evaluations are used in routine eye exams to diagnose astigmatism.

Astigmatism: Treatment Overview

Prescription eyeglasses or contact lenses that adjust for the cornea's or lens's irregular curvature can be used to treat astigmatism. Because toric contact lenses provide varying focusing powers in different eye meridians, they are specifically made to treat astigmatism. The cornea is reshaped during refractive procedures like LASIK and PRK to enhance light focusing and reduce the need for corrective lenses. In orthokeratology (Ortho-K), the cornea is temporarily reshaped for better vision during the day by wearing rigid contact lenses that have been specially made. The degree of astigmatism, lifestyle choices, and general eye health all influence the treatment option.

Epidemiology

The astigmatism epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for astigmatism by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for Astigmatism and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
  • A literature review found that the prevalence of astigmatism ranged from 8% to 62% in the general population, with higher rates among those aged 70 and above. While rates of oblique and against-the-rule astigmatism rose with age, with-the-rule astigmatism was more common in people 40 years of age or younger.
  • A study revealed that if astigmatism is left untreated it can cause amblyopia. 13.2% of eyes with untreated astigmatism of 1.0 D or greater and less than 2.0 D were amblyopic, as were 19.6% of eyes with untreated astigmatism of 2.0 D or greater.
  • In a study conducted, a dominant genetic association in astigmatism was found after analyzing 506 female British twin pairs using data from both eyes in a multivariate model. The estimated heritability for astigmatism was between 50% and 65%, which is less than the 86% quoted for myopia or hyperopia.
  • A study revealed that the mean age of the patients was 42% male and 58% female. It was also reported that astigmatism was present in 40.4% of adults and 14.9% of children.

Country-wise Astigmatism Epidemiology

The astigmatism epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of astigmatism varies between countries owing to the differences in factors such as obesity, tobacco smoking, diabetes and others. A study found that the reported prevalence varied across different countries and regions in 2023, with Germany at 32%, Spain at 54%, Japan at 54%, the United States ranging from 11% to 46%, South Korea from 31% to 58%, and Northern and Western Europe at 27%. China had the highest reported prevalence of astigmatism (62%), out of all the countries/regions included in this review.

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of astigmatism based on several factors.
  • Astigmatism Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population, and the unmet needs of astigmatism are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of astigmatism epidemiology in the 8 major markets?
  • What will be the total number of patients with Astigmatism across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of astigmatism in the 8 major markets in the historical period?
  • Which country will have the highest number of astigmatism patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of astigmatism during the forecast period of 2025-2034?
  • What are the currently available treatments for astigmatism?
  • What are the disease risks, signs, symptoms, and unmet needs of astigmatism?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Astigmatism Market Overview - 8 MM
3.1 Astigmatism Market Historical Value (2018-2024)
3.2 Astigmatism Market Forecast Value (2025-2034)
4 Astigmatism Epidemiology Overview - 8 MM
4.1 Astigmatism Epidemiology Scenario (2018-2024)
4.2 Astigmatism Epidemiology Forecast (2025-2034)
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
5.7 Types of Astigmatism
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM (218-2034)
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Diagnosed Prevalent Cases of Astigmatism
7.4 Type-Specific Cases of Astigmatism
7.5 Gender-Specific Cases of Astigmatism
7.6 Age-Specific Cases of Astigmatism
8 Epidemiology Scenario and Forecast: United States (218-2034)
8.1 Assumptions and Rationale in the US
8.2 Diagnosed Prevalent Cases of Astigmatism in the US
8.3 Type-Specific Cases of Astigmatism in the US
8.4 Gender-Specific Cases of Astigmatism in the US
8.5 Age-Specific Cases of Astigmatism in the US
9 Epidemiology Scenario and Forecast: United Kingdom (218-2034)
9.1 Assumptions and Rationale in United Kingdom
9.2 Diagnosed Prevalent Cases of Astigmatism in United Kingdom
9.3 Type-Specific Cases of Astigmatism in United Kingdom
9.4 Gender-Specific Cases of Astigmatism in United Kingdom
9.5 Age-Specific Cases of Astigmatism in United Kingdom
10 Epidemiology Scenario and Forecast: Germany (218-2034)
10.1 Assumptions and Rationale in Germany
10.2 Diagnosed Prevalent Cases of Astigmatism in Germany
10.3 Type-Specific Cases of Astigmatism in Germany
10.4 Gender-Specific Cases of Astigmatism in Germany
10.5 Age-Specific Cases of Astigmatism in Germany
11 Epidemiology Scenario and Forecast: France (218-2034)
11.1 Assumptions and Rationale in France
11.2 Diagnosed Prevalent Cases of Astigmatism in France
11.3 Type-Specific Cases of Astigmatism in France
11.4 Gender-Specific Cases of Astigmatism in France
11.5 Age-Specific Cases of Astigmatism in France
12 Epidemiology Scenario and Forecast: Italy (218-2034)
12.1 Assumptions and Rationale in Italy
12.2 Diagnosed Prevalent Cases of Astigmatism in Italy
12.3 Type-Specific Cases of Astigmatism in Italy
12.4 Gender-Specific Cases of Astigmatism in Italy
12.5 Age-Specific Cases of Astigmatism in Italy
13 Epidemiology Scenario and Forecast: Spain (218-2034)
13.1 Assumptions and Rationale in Spain
13.2 Diagnosed Prevalent Cases of Astigmatism in Spain
13.3 Type-Specific Cases of Astigmatism in Spain
13.4 Gender-Specific Cases of Astigmatism in Spain
13.5 Age-Specific Cases of Astigmatism in Spain
14 Epidemiology Scenario and Forecast: Japan (218-2034)
14.1 Assumptions and Rationale in Japan
14.2 Diagnosed Prevalent Cases of Astigmatism in Japan
14.3 Type-Specific Cases of Astigmatism in Japan
14.4 Gender-Specific Cases of Astigmatism in Japan
14.5 Age-Specific Cases of Astigmatism in Japan
15 Epidemiology Scenario and Forecast: India (218-2034)
15.1 Assumptions and Rationale in India
15.2 Diagnosed Prevalent Cases of Astigmatism in India
15.3 Type-Specific Cases of Astigmatism in India
15.4 Gender-Specific Cases of Astigmatism in India
15.5 Age-Specific Cases of Astigmatism in India
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights